Janus Living, Inc.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- JanOne Inc. (Nasdaq: JAN) operates as a clinical-stage biopharmaceutical company focused on developing non-opioid, non-addictive therapies for severe pain and addiction, alongside appliance recycling services; its Biotechnology segment advances product candidates including JAN101, a patented oral sustained-release sodium nitrite formulation targeting peripheral artery disease and diabetic neuropathy pain by improving blood flow to extremities, and JAN123, a low-dose naltrexone formulation for complex regional pain syndrome that received U.S. patent approval and FDA orphan drug designation; the Recycling segment, through subsidiary ARCA Recycling, provides turnkey appliance recycling and replacement services for utilities sponsoring energy efficiency programs in North America. The company serves healthcare providers, patients with chronic pain conditions, and utility sponsors, with operations spanning the United States and global fintech expansion potential via recent initiatives. Founded in 1976 and headquartered in Las Vegas, Nevada, JanOne Inc. was formerly Appliance Recycling Centers of America, Inc., changing its name in September 2019 to reflect its pivot toward pain treatment innovation. In May 2024, JanOne completed the acquisition of ALT 5 Sigma Inc., a blockchain financial technology provider offering ALT5 Pay cryptocurrency payment gateway and ALT5 Prime over-the-counter trading platform with over $1.1 billion in 2023 transactional volume, prompting a strategic realignment to enhance stockholder value by potentially separating biotech and fintech operations; the company also confirmed a name change to Alt5 Sigma Corporation with new ticker ALTS in July 2024, appointed Vay Tham as Chief Revenue Officer and ALT5 President in June 2024, and integrated prepaid Visa card functionality into the ALT5 Settlement Platform.
Janus Living Announces Pricing of Public Offering of Class A-1 Common Stock
Janus Living Announces Launch of Public Offering of Class A-1 Common Stock
The Smart Money Is Quietly Buying These REITs
Inflation Reignites, Yields Spike
Janus Living, Inc. (JAN) Q1 2026 Earnings Call Transcript
JAN Q1 Earnings Call Highlights
Janus Living Declares Common Stock Cash Dividends for the First and Second Quarters of 2026
Janus Living Reports First Quarter 2026 Results
Healthpeak Properties Raises 2026 Earnings Guidance Following Completion of the Janus Living IPO, Accretive Capital Allocation, and Strong First Quarter 2026 Results
Head-To-Head Survey: Adamas Trust (NASDAQ:ADAM) vs. JAN (NYSE:JAN)
Financial Survey: Fermi (NASDAQ:FRMI) versus JAN (NYSE:JAN)
Janus Living: Valuation Seems To Have Priced In Near-Term Upsides
Head to Head Contrast: JAN (NYSE:JAN) vs. Fermi (NASDAQ:FRMI)
Fermi (NASDAQ:FRMI) vs. JAN (NYSE:JAN) Critical Comparison
Reviewing Adamas Trust (NASDAQ:ADAM) and JAN (NYSE:JAN)
A Fragile Truce
Janus Living Announces Dates of First Quarter 2026 Earnings Release, Conference Call, and Webcast
John Arabia Buys 60,000 Shares of JAN (NYSE:JAN) Stock
Janus Living: Appealing Real Estate Category With Some Concerns
REITs: A Regime Change Is Needed